Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49770,2718,1.14 [1.08-1.21],7.246623066672054e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,48799,6862,1.11 [1.07-1.15],2.61570628290668e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49002,6268,1.13 [1.09-1.17],8.907042586438114e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,49832,2387,1.14 [1.07-1.22],2.4815088105501023e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46309,1888,1.19 [1.11-1.27],1.4844430673599303e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44749,2154,1.22 [1.14-1.30],2.492567916347268e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35357,3873,1.12 [1.07-1.18],7.175455181416135e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44203,768,1.24 [1.12-1.38],6.829078773383857e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,50255,2810,1.12 [1.06-1.18],0.0001583689149088
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48880,1828,1.16 [1.08-1.25],3.744285402883989e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,50345,2087,1.17 [1.10-1.25],3.3381239031571312e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,50081,1823,1.17 [1.09-1.26],1.3004325270791107e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,47660,215,1.39 [1.15-1.69],0.0008173075617062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lung cancer and mesothelioma,35065,646,1.30 [1.16-1.47],8.212875446771322e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lymphoid leukaemia,40293,102,1.60 [1.23-2.08],0.0004873328634084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,46888,221,1.57 [1.31-1.89],8.62818075971159e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49023,5664,1.14 [1.10-1.19],1.2842076653800628e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,49632,2965,1.14 [1.07-1.20],8.89614351767673e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,49630,2963,1.14 [1.07-1.20],9.514097167374032e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49939,2343,1.30 [1.22-1.38],1.904475408267206e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39153,624,1.30 [1.15-1.46],2.025428327547101e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,49881,3057,1.20 [1.13-1.26],8.986537402086885e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44061,2966,1.21 [1.15-1.28],8.9194825078602e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,45420,6891,1.15 [1.11-1.19],5.846857444842879e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,39616,1087,1.21 [1.10-1.32],7.51004194702557e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50415,643,1.24 [1.10-1.39],0.0003625633007135
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50048,276,1.38 [1.16-1.64],0.0002469816746651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,49515,3049,1.11 [1.05-1.17],0.0002875679139724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39035,506,1.29 [1.13-1.48],0.0001736517143077
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39110,581,1.37 [1.21-1.55],3.724507817095915e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50031,259,1.36 [1.13-1.62],0.0008552835090436
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,48247,9718,1.12 [1.09-1.16],1.402326938713416e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",41631,3102,1.15 [1.09-1.22],5.413405863133222e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,50552,440,1.32 [1.15-1.52],7.679059650588082e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46014,300,1.53 [1.31-1.80],1.283908834731905e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,45838,124,1.63 [1.28-2.08],6.536673121842532e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,49323,3609,1.38 [1.32-1.45],5.972762091944963e-41
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40035,1506,1.21 [1.12-1.31],1.78855274802082e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,46190,2344,1.22 [1.15-1.30],3.4456108047415487e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",48428,389,1.44 [1.25-1.66],3.571379532881659e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47886,4076,1.20 [1.14-1.25],1.2498399523213193e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44119,14794,1.06 [1.03-1.08],3.722745701125003e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",50173,2143,1.18 [1.11-1.26],4.351281049160702e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,45916,12713,1.08 [1.05-1.11],5.658039088050504e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",45953,12750,1.08 [1.05-1.11],2.0362995845772172e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33546,343,1.38 [1.18-1.61],3.807483242293819e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33475,272,1.74 [1.49-2.04],4.889826362081169e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",48221,4375,1.17 [1.11-1.22],7.343112598780426e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49841,1085,1.21 [1.10-1.33],4.045786630305771e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49636,1640,1.15 [1.06-1.24],0.0003388546598178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45229,1383,1.22 [1.13-1.33],7.080361556380706e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50393,301,1.35 [1.15-1.59],0.0003415419134678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48234,195,1.42 [1.16-1.73],0.0005208638406505
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49106,1067,1.21 [1.10-1.32],4.953482564774543e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48774,795,1.39 [1.26-1.53],7.844988400042247e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49818,1246,1.18 [1.08-1.29],0.0001579276001624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49777,1317,1.19 [1.09-1.29],5.70934755552011e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50339,704,0.75 [0.66-0.85],4.401471163093342e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",44247,2810,1.13 [1.07-1.20],4.060890446158681e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,49300,7863,1.13 [1.09-1.17],3.3386881522905188e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",50248,833,0.76 [0.68-0.85],3.082080505807507e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",44551,3114,1.21 [1.15-1.28],1.886065328256547e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,49539,2692,1.29 [1.23-1.36],3.614016418747805e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",44645,3208,1.15 [1.09-1.21],1.2213476802801046e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",50431,579,1.26 [1.11-1.42],0.0002745322550629
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,50232,460,1.34 [1.17-1.53],2.656025760001185e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,48591,5436,1.08 [1.04-1.13],0.0002964142090072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,46528,10289,1.09 [1.06-1.12],5.824934436074424e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Emphysema,43763,608,1.34 [1.19-1.50],5.812241584438686e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48046,556,1.32 [1.17-1.50],7.465495742063919e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,50145,3744,1.13 [1.07-1.18],3.661031140895296e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,48112,622,1.32 [1.17-1.48],3.84985197606185e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50081,1899,1.16 [1.09-1.25],1.9841626574879504e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,50111,3895,1.09 [1.04-1.14],0.0008462533721767
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50396,773,1.30 [1.17-1.45],7.809722131318652e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",49649,3248,1.14 [1.08-1.20],2.4900458576219565e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50038,1856,1.15 [1.07-1.24],7.639211371138312e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",46807,201,1.48 [1.21-1.79],8.870214101873012e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",49757,201,1.46 [1.20-1.78],0.0001529684231692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,48548,1942,1.20 [1.12-1.28],2.446386570840827e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49351,2745,1.14 [1.08-1.21],6.824626871460929e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39165,16222,1.06 [1.03-1.08],9.697348203234072e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47477,282,1.36 [1.14-1.61],0.0004445380437522
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48607,1488,1.19 [1.10-1.28],1.9729806886334864e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49092,1973,1.15 [1.08-1.23],4.855815329964907e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,46654,11041,1.06 [1.03-1.09],0.000299748031149
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),41814,3916,1.09 [1.04-1.14],0.0008554618902129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48849,1730,1.16 [1.08-1.25],7.8852212280264e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",46714,458,1.30 [1.13-1.48],0.0001661565819072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45601,2438,1.13 [1.06-1.21],8.434646289268375e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38173,3184,1.12 [1.06-1.18],0.0001013641015682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,39861,4872,1.12 [1.07-1.17],8.540208795707763e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,48517,3086,1.23 [1.16-1.29],1.1931302037239365e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,48438,3007,1.27 [1.20-1.34],1.5376970772221576e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,50155,164,1.53 [1.24-1.89],9.319257128769492e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dialysis,45590,159,1.87 [1.54-2.26],1.3613729675610196e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,42188,10506,1.07 [1.04-1.11],7.903168383427112e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,48525,4415,1.09 [1.04-1.14],0.0005024801460573
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50441,937,1.31 [1.19-1.44],1.8568129594715017e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,47504,3394,1.11 [1.06-1.17],6.832507322708913e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45506,665,1.23 [1.09-1.38],0.0005280942681997
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,49815,311,1.37 [1.16-1.61],0.0001495654171231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,50084,5243,1.19 [1.14-1.24],2.502217964881389e-16
